Skip to main content
Caplight Logo









AiTreat

AiTreat

Private
SingaporeHealthcare & Life Scienceshttps://www.aitreat.com/

Last Round

Pre Seed

Dec 1, 2020

Est. Valuation

$7.3M

Total Funding Raised

$2M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

AiTreat operates in Healthcare & Life Sciences and is based in Singapore. Its latest recorded funding round was a Pre Seed round in December 2020.

AiTreat is a healthcare technology company that designs and integrates assistive medical robots to assist physicians in providing therapeutic care to patients.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Industrial Robotics, Medical AI, Enterprise Resource Planning

Business Model

B2B

Customer Profile

Hardware Sales, Subscription SaaS

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

AiTreat Comparables

Compare AiTreat with similar companies based on industry and business-model similarity.

AiTreat comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Shenzhen Deyee Medical Technology Co., Ltd.
83%
Massage Robotics
81%
Ehave, Inc.
79%
Book a demo to see all comparables

For institutional investors. Book with your work email.

AiTreat Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Pre SeedDec 1, 2020
SeedOct 9, 2017
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

AiTreat Investors

Notable investors and investment history

AiTreat investors
InvestorRounds
Brain Robotics CapitalSeries A, Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 21, 2026

    Monthly visitors increased 48% MoM.

  • Oct 9, 2017

    Raised $7.3M post-money round with Brain Robotics Capital.

Book a demo to see all signals

For institutional investors. Book with your work email.

AiTreat Filings

Explore SEC and related filing metadata, where available.

AiTreat filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about AiTreat's valuation, stock price, and market status.

Is AiTreat a public or private company?

AiTreat is a private company.

What is the current stock price of AiTreat?

AiTreat is a private company, so its shares have no public market price. Caplight tracks AiTreat's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is AiTreat worth (valuation)?

AiTreat's valuation is estimated at $7.3M based on funding round data.

Can I buy AiTreat stock?

AiTreat shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was AiTreat's last funding round?

AiTreat's most recent funding round was Pre Seed on December 1, 2020.

Who are the main investors in AiTreat?

Key investors in AiTreat include Brain Robotics Capital.

Will AiTreat IPO soon?

No public IPO plans have been announced for AiTreat.

How can I track AiTreat secondary market activity?

Caplight tracks bids, offers, and trades in AiTreat's shares on secondary markets.

Firmographic Details

HeadquartersSingapore
Employee Range16
Year Founded2015
Last FundingDec 1, 2020

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?